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Abstract
Background and Aims Atrial fibrillation (AF) is the most
frequent arrhythmia in elderly patients. Aims of this study
were to evaluate the predictors of arterial stiffness after
external cardioversion (ECV) of AF and to establish
whether a link exists between vascular properties and left
atrial diameter (LAD).
Methods We studied 33 patients (age 73 ± 12 years).
After 5 h from ECV of persistent AF, an echocardiogram
was recorded and arterial stiffness was evaluated with
cardio-ankle vascular stiffness index (CAVI).
Results In multivariate analysis (R = 0.538, p = 0.006),
CAVI (mean 9.60 ± 1.63) increased with age (p = 0.018)
and with an AF length B3 months (p = 0.022). LAD was
significantly related to CAVI (p = 0.007) even after
adjustment for interventricular septum thickness (p =
0.018) (R = 0.574, p = 0.002).
Conclusions In patients with AF, immediately after ECV,
arterial stiffness is associated with age and AF length, and
could represent an important factor for left atrium remod-
eling and, therefore, for AF maintenance.
Keywords Arterial stiffness  Atrial fibrillation 
CAVI  Elderly  External cardioversion  Left atrium
diameter
Introduction
Atrial fibrillation (AF) is the most common sustained
arrhythmia in the elderly [1]; its prevalence is justified by
cardiovascular aging and the age-related increase of
comorbidity [1–3]. Arterial stiffness (AS) also increases
with age and predicts coronary heart disease, stroke and
mortality [4]. The endpoint of this study was to define the
clinical determinants of AS in subjects with persistent AF
immediately after external cardioversion (ECV). Further-
more, we assessed the existence of a link between left
atrium (LA) diameter (LAD) and AS.
Methods
Patients and procedures
We enrolled all patients admitted to a day-hospital for ECV
of persistent AF between January and June 2013; the only
exclusion criterion was non-restoration of SR. The protocol
was approved by an institutional committee and conforms
to the 1975 Declaration of Helsinki ethical guidelines;
patients gave their consent to participate. ECV was per-
formed using a biphasic defibrillator, after a 4-week period
of effective oral anticoagulation [1]. An echocardiogram
was digitally recorded 5 h after the procedure.
Measure of AS
The cardio-ankle vascular index (CAVI) [5], a measure of
AS, independent from instantaneous systolic and pulse
pressure, was determined using VaSera VS-1500N (Fukuda
Denshi, Japan) after 20 min of rest in supine position.
During the continuous recording of EKG and heart sounds,
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right and left upper and lower extremity arterial pressure
was obtained with the oscillometric method. Pulse wave
velocity (PWV) was calculated dividing the distance from
the aortic valve to the ankle artery (an indirect measure
derived from the height of the patient) by the sum of two
time intervals [(1) aortic valve closing sound—notch of the
brachial pulse wave; (2) rise of the brachial pulse wave—
rise of the ankle pulse wave] [5]. CAVI was then computed
using the following equation:
CAVI ¼ a  2q=DPð Þ  ln Ps=Pdð Þ  PWV2
 þ b
where Ps/Pd are systolic/diastolic pressures, DP is ‘‘Ps–
Pd’’, q is blood density, and a/b are constants [5]. CAVI
was measured after SR restoration to avoid bias due to
different RR intervals [5].
Statistical analysis
IBM SPSS for Windows (ver. 20) was used for statistical
analysis. Continuous variables were expressed as
mean ± SD, categorical variables as numbers with per-
centages. Student’s t test and analysis of variance were
used to compare continuous variables. The association
between categorical variables was evaluated with v2 test.
Linear regression analysis models were used to define
univariate and multivariate predictors of CAVI and LAD.
A p value \0.05 was considered statistically significant.
Results
Patients’ description
Thirty-three patients underwent ECV (Table 1). Median
AF length was 3 months (range 1–18). Right arm arterial
pressure and right ankle-brachial index were 140 ± 16/
85 ± 11 mmHg and 1.10 ± 0.15, respectively, with no
difference between right- and left-side measurements.
Thromboembolic risk (CHADS2 score) was moderate in
72.7 % and high in 18.3 % of cases. Beta-blockers, ACE-
inhibitors or angiotensin receptor blocking agents were the
most frequently used cardiovascular drugs (Table 1). There
was no difference between right and left CAVI
(9.60 ± 1.63 and 9.56 ± 1.64, respectively; p = 0.78).
Therefore, only the results related to right CAVI will be
presented.
CAVI determinants
In univariate analysis, CAVI was significantly associated
with age (R = 0.390, p = 0.025), BMI (R = 0.364,
p = 0.037), the presence of mitral regurgitation (yes:
10.3 ± 1.4 vs. no: 8.9 ± 1.6, p = 0.012) and an AF
length B3 months (yes: 10.1 ± 1.5 vs. no: 8.9 ± 1.5,
p = 0.031). CAVI was not affected by gender or current
smoking status, nor did we find any link with arterial
hypertension, CHF, chronic renal failure, coronary artery
and cerebrovascular disease, diabetes, dyslipidemia or
other causes of AF. Heart rate, systolic, diastolic and pulse
pressure, hemoglobin concentration and drug therapy did
not correlate with CAVI. Interventricular septum thickness,
Table 1 Patients’ clinical characteristics
(n = 33) Range
Age (years) 73 ± 12 35–90
Men (n, %) 28 (84.8)
Height (cm) 174 ± 9 150–192
Weight (Kg) 82 ± 15 56–138
BMI (Kg/m2) 27.0 ± 5.0 19.8–48.9
Present smokers (n, %) 7 (21.2)
CAD (n, %) 6 (18.2)
CHF (n, %) 11 (33.3)
CKD (n, %) 5 (15.2)
CVD (n, %) 2 (6.1)
Diabetes (n, %) 4 (12.1)
Dyslipidemia (n, %) 12 (36.4)
Hypertension (n, %) 22 (66.7)
LAF/brady-tachycardia syndrome (n, %) 6 (18.2)
Valvular disease (n, %)
Aortic regurgitation 7 (21.2)
Aortic stenosis/prosthesis 4 (12.1)
Mitral regurgitation 17 (51.5)
CHADS2 (score) 1.8 ± 1.3 0–5
Pulse Pressure (mmHg) 57 ± 13 34–95
LAD (mm) 50 ± 7 35–63
Interventricular septum (mm) 10 ± 1.5 7–12
LVEDD (mm) 56 ± 9 43–86
LVESD (mm) 39 ± 10 24–71
LVEF (%) 56 ± 14 20–79
Hemoglobin (g/dL) 14.0 ± 1.7 11.0–17.3
Creatinine (mg/dL) 0.9 ± 0.3 0.4–1.6
ACE-I/ARB (n, %) 27 (81.8)
b-blockers (n, %) 25 (75.8)
Ca-antagonists (n, %) 5 (15.2)
Digoxin (n, %) 15 (45.5)
Statins (n, %) 9 (27.3)
BMI body mass index, CAD coronary artery disease, CHF chronic
heart failure, CKD chronic kidney disease, CVD cerebro-vascular
disease, Interventricular septum Interventricular septum thickness,
LAF lone atrial fibrillation, Brady-Tachycardia Syndrome bradycar-
dia-tachycardia syndrome, Prosthesis biological or mechanical aortic
prosthetic valve, LAD left atrium end-systolic diameter, LVEDD/
LVESD left ventricular end-systolic/end-diastolic diameter, LVEF left
ventricular ejection fraction, ARB angiotensin receptor blocking
agents, Ca-antagonists dihydropyridine Ca-antagonists
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left ventricular (LV) diameters, and LVEF were not asso-
ciated with CAVI, but LAD was (R = 0.435, p = 0.011).
A multivariate regression analysis model (R = 0.538,
p = 0.006) showed that age (b = 0.05 ± 0.02, 95 %
CI = 0.01–0.09, p = 0.018) and an AF length B3 months
(b = 1.20 ± 0.50, 95 % CI = 0.18–2.22, p = 0.018) were
significantly related to CAVI, while BMI lost its statistical
significance (p = 0.11).
LAD determinants
LAD was not associated with age, gender, BMI, comorbid
conditions, mitral regurgitation, AF length, drugs, arterial
pressure, LV diameters, LVEF or hemoglobin concentration.
Apart from CAVI, only interventricular septum thickness
showed a direct association with atrial dimensions (R = 0.378,
p = 0.030). A multivariate model (overall R = 0.574,
p = 0.002) demonstrated that both interventricular septum
thickness (b = 1.82 ± 0.73, 95 % CI = 0.34–3.30,
p = 0.018) and CAVI (b = 1.92 ± 0.66, 95 %
CI = 0.56–3.27, p = 0.007) were predictors of LAD (Fig. 1).
Discussion
The results of this preliminary study confirm the existence
of a direct relationship between CAVI and age, also in
patients treated with ECV for persistent AF. Interestingly, a
shorter length of AF seems to be associated with higher
CAVI values. We also showed that AS, together with
interventricular septum thickness, is a significant determi-
nant of LAD.
The inverse correlation between CAVI and duration of
AF, observed in the first few months after arrhythmia
development, might be attributed to the increase in after-
load due to the early effects on cardiac performance
associated with the loss of atrial systole [6].
Few data exist aimed at clarifying the interaction among
AF, LAD and AS, and results are sometimes conflicting. In
a previous study, Reiffel [7] found that AS and LV
hypertrophy did not predict the risk of AF in hypertensive
patients and concluded that the arrhythmia is generated by
complex mechanisms induced by atrial hypertension. On
the contrary, Lantelme and colleagues [8] showed that in
hypertensive patients LAD correlated with PWV or pulse
pressure, suggesting that AF could be a link between AS
and stroke. Finally, patients with obstructive sleep apnea
showed a direct correlation between LAD and AS [9]. LA
and LV act in synergy; atrial volume has been proven to
express the severity of ventricular diastolic dysfunction in
patients without atrial arrhythmias or valvular heart disease
[10]. However, the association of LAD with diastolic
dysfunction cannot fully explain our results. In fact, CAVI
remained independently correlated with atrial dimensions
even after adjustment for interventricular septum thickness,
a parameter linked with altered LV relaxation [11]. A
possible explanation of the link between AS and LAD we
found in this study could be represented by mitral regur-
gitation, present in 51.5 % of our patients and associated
with higher CAVI values. In addition, AS seems to pro-
mote inflammation, vascular smooth muscle cell contrac-
tion, and stretch-induced release of metalloproteinase-12 in
atrial tissues [12]. To further stress the importance of non-
mechanical factors in the complex network linking LA, LV
and arterial properties, a recent review suggests that
comorbidities can produce coronary micro-vascular dys-
function, mediated by inflammation, ultimately leading to
myocardial stiffness progression [13]. All these data sup-
port the existence of a connection between AS and AF.
Study limitations
The study is preliminary and the sample is small, with only
5 women. The echocardiogram was recorded 5 h after
effective ECV; yet, current evidence seems to suggest that
such a short period of SR is unable to revert the electrical
and structural changes which characterize atrial remodeling
[14]. Finally, our results might have been different had we
Fig. 1 Association between left
atrium diameter and Cardio-
Ankle Vascular Index (left) and
interventricular septum
thickness (right) in patients with
persistent atrial fibrillation
evaluated after successful
external cardioversion
(univariate regression analysis
model)
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performed pharmacological cardioversion; however, ECV
is the treatment of choice for AF lasting [48 h [1].
In conclusion, the results of our preliminary study sup-
port the hypothesis that age-related AS is independently
associated with atrial size in patients with persistent AF.
Therefore, the concept that ‘‘atrial fibrillation begets atrial
fibrillation’’ [15] might rely also on a ‘‘vascular’’ compo-
nent. Further studies are needed to confirm present findings
and to clarify if AS may exert a role in arrhythmia
recurrence.
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